University of Iowa Hospitals and Clinics is an 811-bed public teaching hospital and level 1 trauma center affiliated with the University of Iowa.

There are 811 beds in University of Iowa Hospitals and Clinics.

During the past decade, University of Iowa Hospitals and Clinics conducted 465 clinical trials. In the 10-year time frame, 465 clinical trials started and 287 clinical trials were completed, i.e. on average, 61.7% percent of trials that started reached the finish line to date. In the past 5 years, 157 clinical trials started and 154 clinical trials were completed. i.e. 98.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Iowa Hospitals and Clinics" #1 sponsor was "University of Iowa" with 63 trials, followed by "Gynecologic Oncology Group" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "Children's Oncology Group" with 22 trials sponsored and "Pfizer" with 22 trials sponsored. Other sponsors include 811 different institutions and companies that sponsored additional 428 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Iowa Hospitals and Clinics" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "University of Iowa" with 26 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 25 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator and "National Institutes of Health (NIH)" with 12 trials as a collaborator. Other collaborators include 500 different institutions and companies that were collaborators in the rest 298 trials.

According to Clinical.Site data, the most researched conditions in "University of Iowa Hospitals and Clinics" are "Pulmonary Arterial Hypertension" (25 trials), "Breast Cancer" (17 trials), "Ovarian Cancer" (17 trials), "Sarcoma" (17 trials) and "Leukemia" (16 trials). Many other conditions were trialed in "University of Iowa Hospitals and Clinics" in a lesser frequency.

Most popular intervention types in "University of Iowa Hospitals and Clinics" are "Drug" (630 trials), "Device" (120 trials), "Biological" (113 trials), "Other" (106 trials) and "Procedure" (79 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (140 trials), "cyclophosphamide" (23 trials), "Pembrolizumab" (19 trials), "cisplatin" (19 trials) and "doxorubicin hydrochloride" (18 trials). Other intervention names were less common.

The vast majority of trials in "University of Iowa Hospitals and Clinics" are 861 trials for "All" genders, 86 trials for "Female" genders and 26 trials for "Male" genders.

Currently, there are NaN active trials in "University of Iowa Hospitals and Clinics". undefined are not yet recruiting, 155 are recruiting, 110 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 536 completed trials in University of Iowa Hospitals and Clinics, undefined suspended trials, and 114 terminated clinical trials to date.

Out of the total trials that were conducted in University of Iowa Hospitals and Clinics, 123 "Phase 1" clinical trials were conducted, 328 "Phase 2" clinical trials and 267 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 52 trials, and there were also 163 trials that are defined as “Not Applicable".

University of Iowa Hospitals and Clinics has several departments that took part in Clinical trials: "Univ. of Iowa Healthcare, Div. of Infectious Diseases" - 26 trials, "University of Iowa Hospitals & Clinics - Department of Internal Medicine" - 6 trials, "University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics" - 3 trials, "University of Iowa Pulmonary Hypertension Program" - 2 trials, "University of Iowa Hospital & Clinic; Division of Hematology/Oncology" - 2 trials